Acorda Therapeutics Acquires Civitas Therapeutics for $525,000,000
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2c29f799-022d-47f4-a179-9c25c3e5ccb9 - Date
9/24/2014 - Company Name
Civitas Therapeutics - Mailing Address
190 Everett Ave. Chelsea, MA 02150 USA - Company Description
Civitas is a pharmaceutical company focused on developing products with a clinically proven dry powder pulmonary delivery platform. The proprietary dry powder and device combination is unique in its ability to deliver a large, precise dose independent of inspiratory flow rate from a simple, passive device. - Website
http://www.civitastherapeutics.com - Transaction Type
M&A - Transaction Amount
$525,000,000 - Transaction Round
- Proceeds Purposes
- M&A Terms
Acorda Therapeutics announced that it entered into an agreement to acquire Civitas Therapeutics, a privately-held biopharmaceutical company, for $525 million in cash.
